122 related articles for article (PubMed ID: 3290546)
1. [Production of CA19-9 in cultured human gastric cancer cell lines].
Natomi H; Sugano K; Iwamori M; Saito E; Kubota S; Kondo Y; Osawa N; Takaku F
Nihon Shokakibyo Gakkai Zasshi; 1988 Feb; 85(2):236-42. PubMed ID: 3290546
[No Abstract] [Full Text] [Related]
2. [Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4].
Sagredo E; Soriano A; Vivanco FJ; Ruibal A
Rev Clin Esp; 1989 Apr; 184(6):336-7. PubMed ID: 2756226
[No Abstract] [Full Text] [Related]
3. [Establishment, in nude mice, of a serially transplantable human stomach cancer (KUM X MK-2) producing plural tumor markers--human stomach cancer producing CEA, CA19-9, KM01].
Inufusa H
Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2264. PubMed ID: 3469450
[No Abstract] [Full Text] [Related]
4. [Fetoproteins of human cancer].
Muñóz y Fernández JR; Arraiza Giucoechea A
Rev Clin Esp; 1974 Feb; 132(4):287-98. PubMed ID: 4364674
[No Abstract] [Full Text] [Related]
5. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
6. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9].
Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I
Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214
[TBL] [Abstract][Full Text] [Related]
7. [The comparative study of biological behavior between primary lesion and metastatic lymph node of gastric cancer--immunohistochemical study of CEA and CA 19-9].
Takahashi Y; Minami S; Mai M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2233-4. PubMed ID: 3459399
[No Abstract] [Full Text] [Related]
8. [The relation between serum carcinoembryonic antigens (CEA) and response to chemotherapy in patients with advanced gastric cancer].
Saito D; Yoshida S; Hijikata A; Tajiri H; Yamaguchi H; Yoshimori M; Ohkura H; Okazaki N; Yoshida T; Yoshino M
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):948-57. PubMed ID: 3480325
[No Abstract] [Full Text] [Related]
9. Recent studies of glycolipid and glycoprotein profiles and characterization of the major glycolipid antigen in gastric cancer of a patient of blood group genotype pp (Tja-) first studied in 1951.
Kannagi R; Levine P; Watanabe K; Hakomori S
Cancer Res; 1982 Dec; 42(12):5249-54. PubMed ID: 7139617
[No Abstract] [Full Text] [Related]
10. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
[TBL] [Abstract][Full Text] [Related]
11. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
Staab HJ
Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
[No Abstract] [Full Text] [Related]
12. [Comparative study with reduction rate of tumor and decrease rate of tumor markers as an effect of MMC on human cancer producing CEA and CA19-9 xenotransplanted in nude mice].
Takahashi Y; Ohta T; Mai M
Nihon Geka Gakkai Zasshi; 1987 Apr; 88(4):502. PubMed ID: 3108655
[No Abstract] [Full Text] [Related]
13. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of two glycolipid tissue antigens in human gastric carcinoma.
Wang SM; Huang TW; Hakomori S
Cancer; 1983 Dec; 52(11):2072-6. PubMed ID: 6354423
[TBL] [Abstract][Full Text] [Related]
16. [Tumor markers in gastrointestinal cancer and its clinical significance].
Taguchi T; Ota J; Sumida S; Rii M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
[TBL] [Abstract][Full Text] [Related]
17. [Carcinoembryonic antigen, Ca 19-9 and Ca 125 antigen levels in the sera of patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Pol Tyg Lek; 1988 Feb; 43(5):136-9. PubMed ID: 3165528
[No Abstract] [Full Text] [Related]
18. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
19. Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies.
Sakahara H; Saga T; Endo K; Kousaka T; Hosono M; Kobayashi H; Shirato M; Konishi J
Br J Cancer; 1993 Nov; 68(5):920-5. PubMed ID: 8217607
[TBL] [Abstract][Full Text] [Related]
20. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER].
Buda F; Aragona P; Giani G; Sisto R; Di Nardo G; Binotto F; Gangemi P; De Zerbi T; Gentile G; Papadia A
G Ital Oncol; 1989; 9(2-3):67-72. PubMed ID: 2767730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
